Suzhou Onkocare Medical Laboratory
Medical Laboratory

Suzhou Onkocare Medical Laboratory is an independent third-party medical laboratory under Onkocare Group, which has obtained a medical institution practice license. It is a medical laboratory that focuses on tumor gene testing as its core business and provides patients with comprehensive and accurate tumor management services.
Suzhou Onkocare Medical Laboratory has an area of over 1200 square meters and is managed in a standardized quality system in accordance with the requirements of ISO15189 quality management system and CAP system certification. The laboratory focuses on building a high-level genetic testing service platform and a standardized clinical new testing project transformation platform, providing accurate and reliable technical support for medical personnel, and providing valuable testing services to the public.
-
Tumor Genetics
Risk assessment
-
Early screening
-
Auxiliary diagnosis
-
Postoperative evaluation
-
Precision medication
-
Efficacy monitoring
-
Drug resistance assessment
-
Recurrence monitoring

Cervical cancer gene methylation detection
Cervical exfoliated cell methylation detection, targeting high-risk HPV positive patients in the initial screening, is a pre colposcopy triage auxiliary diagnosis, and also serves as a detection method for cervical cancer auxiliary diagnosis.

Tumor medication guidance testing
Before receiving treatment, diagnostic analysis of the patient's body biomarkers can provide the best treatment plan and maximize the effectiveness of tumor treatment.
Meanwhile, the benefits also include avoiding overtreatment and reducing the financial burden on patients, as well as reducing the waste of medical resources.

Special inspection items
The joint examination of the four cancers of the digestive tract, aimed at early screening of intestinal, liver, stomach, and pancreatic lesions, can not only evaluate the risk of the disease, but also trace the source of the risk location.